Skip to main content
Clinical Trials/NCT06193109
NCT06193109CompletedNot Applicable

The Prognostic Impact of Right Ventricular Systolic Dysfunction on the Survival of Patients With Sepsis and Septic Shock

Burapha University1 site in 1 country200 target enrollmentStarted: October 1, 2022Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
200
Locations
1
Primary Endpoint
28 days in-hospital mortality

Study Overview

Brief Summary

This study sought to evaluate the association of right ventricular systolic dysfunction and 28-day in-hospital mortality in patients with sepsis and septic shock. Prospective cohort study of adult patients admitted at Burapha university hospital from October 1, 2022 through June 30, 2023 for sepsis and septic shock, who had an echocardiogram within 72 hours after admission for evaluating right ventricular systolic function. Right ventricular systolic dysfunction was defned by the American Society of Echocardiography criteria. Outcomes included 28-day in-hospital mortality, maximal blood lactate, length of intensive care unit(ICU) stay and duration of mechanical ventilation.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • aged 18 years or older
  • diagnosed with sepsis or septic shock according to Sepsis-3 criteria
  • received an echocardiogram within 72 hours after admission

Exclusion Criteria

  • prior diagnosis of pulmonary hypertension,
  • cor-pulmonale,
  • significant valvular heart disease,
  • acute coronary syndrome,
  • aortic dissection,
  • heart failure
  • inability to follow up within 28 days

Outcomes

Primary Outcomes

28 days in-hospital mortality

Time Frame: October 1, 2022 and June 30, 2023

28 days in hospital mortality in patients with sepsis or septic shock

Secondary Outcomes

  • Duration of mechanical ventilation(October 1, 2022 and June 30, 2023)
  • The prevalence of right ventricular systolic dysfunction(October 1, 2022 and June 30, 2023)
  • Blood lactate levels(October 1, 2022 and June 30, 2023)
  • Lenght of ICU stay(October 1, 2022 and June 30, 2023)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Sukrisd Koowattanatianchai

Assistant Professor Dr.

Burapha University

Study Sites (1)

Loading locations...

Similar Trials

The Prognostic Impact of Right Ventricular... | Clinical Trial